T. Rowe Price Associates’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$208K Buy
14,793
+520
+4% +$7.31K ﹤0.01% 2696
2025
Q1
$193K Buy
14,273
+2,891
+25% +$39.1K ﹤0.01% 2656
2024
Q4
$201K Sell
11,382
-6,496
-36% -$115K ﹤0.01% 2669
2024
Q3
$343K Buy
17,878
+67
+0.4% +$1.29K ﹤0.01% 2414
2024
Q2
$389K Buy
17,811
+3,983
+29% +$87K ﹤0.01% 2292
2024
Q1
$530K Buy
13,828
+2,472
+22% +$94.7K ﹤0.01% 2188
2023
Q4
$764K Buy
11,356
+2,782
+32% +$187K ﹤0.01% 1993
2023
Q3
$642K Buy
8,574
+884
+11% +$66.2K ﹤0.01% 1990
2023
Q2
$709K Buy
7,690
+512
+7% +$47.2K ﹤0.01% 1970
2023
Q1
$745K Sell
7,178
-63
-0.9% -$6.54K ﹤0.01% 1921
2022
Q4
$835K Buy
7,241
+388
+6% +$44.7K ﹤0.01% 1863
2022
Q3
$743K Sell
6,853
-557
-8% -$60.4K ﹤0.01% 1916
2022
Q2
$1.34M Sell
7,410
-1,676
-18% -$303K ﹤0.01% 1752
2022
Q1
$1.55M Buy
9,086
+349
+4% +$59.6K ﹤0.01% 1795
2021
Q4
$1.83M Sell
8,737
-215
-2% -$45K ﹤0.01% 1751
2021
Q3
$1.73M Sell
8,952
-1
-0% -$193 ﹤0.01% 1793
2021
Q2
$2.53M Sell
8,953
-265
-3% -$75K ﹤0.01% 1653
2021
Q1
$1.95M Sell
9,218
-1,308
-12% -$277K ﹤0.01% 1729
2020
Q4
$2.07M Sell
10,526
-1,462
-12% -$287K ﹤0.01% 1622
2020
Q3
$1.97M Buy
11,988
+1,872
+19% +$308K ﹤0.01% 1555
2020
Q2
$1.4M Sell
10,116
-2,510
-20% -$348K ﹤0.01% 1656
2020
Q1
$789K Sell
12,626
-2,095
-14% -$131K ﹤0.01% 1799
2019
Q4
$1.61M Buy
14,721
+434
+3% +$47.6K ﹤0.01% 1682
2019
Q3
$1.48M Buy
14,287
+50
+0.4% +$5.18K ﹤0.01% 1655
2019
Q2
$1.83M Buy
14,237
+31
+0.2% +$3.98K ﹤0.01% 1616
2019
Q1
$1.81M Buy
14,206
+8,068
+131% +$1.03M ﹤0.01% 1621
2018
Q4
$767K Buy
6,138
+192
+3% +$24K ﹤0.01% 1911
2018
Q3
$1.32M Buy
5,946
+2,278
+62% +$505K ﹤0.01% 1758
2018
Q2
$587K Buy
3,668
+17
+0.5% +$2.72K ﹤0.01% 2063
2018
Q1
$341K Buy
3,651
+21
+0.6% +$1.96K ﹤0.01% 2221
2017
Q4
$253K Hold
3,630
﹤0.01% 2323
2017
Q3
$216K Buy
+3,630
New +$216K ﹤0.01% 2373
2016
Q3
Sell
-6,730
Closed -$224K 2548
2016
Q2
$224K Buy
+6,730
New +$224K ﹤0.01% 2284